Patents by Inventor Steven C. Quay

Steven C. Quay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12281056
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifen, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Grant
    Filed: October 31, 2023
    Date of Patent: April 22, 2025
    Assignee: ATOSSA THERAPEUTICS, INC.
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Patent number: 12275684
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Grant
    Filed: May 7, 2024
    Date of Patent: April 15, 2025
    Assignee: ATOSSA THERAPEUTICS, INC.
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Publication number: 20250066286
    Abstract: Described herein are methods of making (Z)-endoxifen, a salt thereof, crystalline forms of endoxifen, and compositions comprising them. Also described herein are crystalline forms of (Z)-endoxifen. A method of making (Z)-endoxifen may include one or more enrichment steps to enrich the amount of (Z)-endoxifen present in a composition. Enrichment may include one or more steps of crystallization, recrystallization, or fractional recrystallization to reduce the level of one or more impurities in the composition. These methods may be industrially scalable. Also described herein are compositions enriched for (Z)-endoxifen produced by the methods described herein.
    Type: Application
    Filed: January 11, 2023
    Publication date: February 27, 2025
    Inventors: Steven C. Quay, Yao-Lin SUN, Wei-Jen LO, Kun-Chih HUNG, Chia-Chen HSU
  • Patent number: 12201591
    Abstract: The present disclosure provides sustained release compositions of (Z)-endoxifen and polymorphs and salts thereof and methods of making sustained release compositions of (Z)-endoxifen and polymorphs and salts thereof. The present disclosure also provides methods for treating disorders susceptible to (Z)-endoxifen, including hormone dependent disorders and mood disorders.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: January 21, 2025
    Assignee: Atossa Therapeutics, Inc.
    Inventors: Steven C. Quay, Naresh Kumar Reddy Vutukuru, Srinivasan Shanmugam
  • Publication number: 20240425443
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: May 7, 2024
    Publication date: December 26, 2024
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Publication number: 20240327333
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifen, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: October 31, 2023
    Publication date: October 3, 2024
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Patent number: 12071391
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: August 27, 2024
    Assignee: ATOSSA THERAPEUTICS, INC.
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Publication number: 20240148675
    Abstract: The present disclosure provides novel topical compositions comprising endoxifen and salts and solvates thereof and methods for making the compositions. Certain compounds have been combined to make a stable topical compositions comprising endoxifen. The present disclosure also provides methods for treatment of hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: June 20, 2023
    Publication date: May 9, 2024
    Applicant: Atossa Therapeutics, Inc.
    Inventors: Steven C. Quay, Avadhesh S. Kushwaha, Edward T. Kisak, John M. Newsam
  • Publication number: 20230365490
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: March 30, 2023
    Publication date: November 16, 2023
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Patent number: 11680036
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Grant
    Filed: December 29, 2022
    Date of Patent: June 20, 2023
    Assignee: ATOSSA THERAPEUTICS, INC.
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Publication number: 20230183166
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: December 29, 2022
    Publication date: June 15, 2023
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Patent number: 11572334
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Grant
    Filed: January 20, 2022
    Date of Patent: February 7, 2023
    Assignee: ATOSSA THERAPEUTICS, INC.
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Publication number: 20220242816
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifin, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: January 20, 2022
    Publication date: August 4, 2022
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Patent number: 11261151
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifen, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: March 1, 2022
    Assignee: Atossa Therapeutics, Inc.
    Inventors: Steven C. Quay, Yao-Lin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Publication number: 20210060052
    Abstract: The present disclosure relates to intraductal methods and compositions for inducing immune response in subjects having breast cancer. The intraductally administered compositions comprise one or more bioactive agents capable of inducing in situ maturation of antigen presenting cells and migration of mature antigen presenting cells to lymph nodes. The intraductal methods and compositions induce the activation of effector immune cells, and augment tumor cell death.
    Type: Application
    Filed: March 11, 2019
    Publication date: March 4, 2021
    Applicant: Atossa Therapeutics, Inc.
    Inventor: Steven C. Quay
  • Publication number: 20210000920
    Abstract: The present invention relates to intraductal methods and compositions for treating subjects having breast disorders. Compositions comprise repolarizing agents and polarization blockading agents capable of repolarizing M2-macrophages to M1-macrophages in the tumor microenvironment, decreasing M2-macrophages, increasing M1-macrophages and/or increasing sensitivity to chemotherapy in the subject.
    Type: Application
    Filed: December 20, 2018
    Publication date: January 7, 2021
    Applicant: Atossa Therapeutics, Inc.
    Inventor: Steven C. Quay
  • Publication number: 20200268690
    Abstract: The present disclosure provides a novel topical composition comprising at least one active agent and method for making the composition. Certain compounds have been combined to make a stable composition comprising at least one active agent such as selective estrogen receptor modulators and aromatase inhibitors. The present disclosure also provides methods for treatment of hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: September 10, 2018
    Publication date: August 27, 2020
    Applicant: Atossa Therapeutics, Inc.
    Inventors: Steven C. Quay, Avadhesh S. Kushwaha, Edward T. Kisak, John M. Newsam
  • Publication number: 20200215006
    Abstract: The present disclosure provides novel topical compositions comprising endoxifen and salts and solvates thereof and methods for making the compositions. Certain compounds have been combined to make a stable topical compositions comprising endoxifen. The present disclosure also provides methods for treatment of hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: September 10, 2018
    Publication date: July 9, 2020
    Applicant: Atossa Therapeutics, Inc.
    Inventors: Steven C. Quay, Avadhesh S. Kushwaha, Edward T. Kisak, John M. Newsam
  • Publication number: 20200207704
    Abstract: The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a salt thereof, crystalline forms of endoxifen, and compositions comprising them. The present disclosure also provides methods for treating hormone-dependent breast and hormone-dependent reproductive tract disorders.
    Type: Application
    Filed: September 10, 2018
    Publication date: July 2, 2020
    Inventors: Steven C. Quay, YaoLin Sun, LungHu Wang, ChangJung Wu, ChuanDer Huang
  • Publication number: 20190298771
    Abstract: The present invention relates to compositions and transpapillary methods of adoptive cell therapy for the treatment of subjects having or at risk of having breast disorders.
    Type: Application
    Filed: September 25, 2017
    Publication date: October 3, 2019
    Applicant: ATOSSA GENETICS INC.
    Inventor: Steven C. Quay